(Q37466388)

English

Quality of life predicts progression-free survival in patients with metastatic renal cell carcinoma treated with sunitinib versus interferon alfa

scientific article published on March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

Quality of life predicts progression-free survival in patients with metastatic renal cell carcinoma treated with sunitinib versus interferon alfa (English)

1 reference

Europe PubMed Central

20 August 2017

quality of life

1 reference

based on heuristic

inferred from title

interferon alfa

1 reference

based on heuristic

inferred from title

renal cell carcinoma

1 reference

based on heuristic

inferred from title

metastatic renal cell carcinoma

1 reference

based on heuristic

inferred from title

9

object named as

Robert J Motzer

1 reference

Europe PubMed Central

20 August 2017

1

object named as

David Cella

1 reference

Europe PubMed Central

20 August 2017

author name string

Joseph C Cappelleri

2

1 reference

Europe PubMed Central

20 August 2017

Andrew Bushmakin

3

1 reference

Europe PubMed Central

20 August 2017

Claudie Charbonneau

4

1 reference

Europe PubMed Central

20 August 2017

Jim Z Li

5

1 reference

Europe PubMed Central

20 August 2017

Sindy T Kim

6

1 reference

Europe PubMed Central

20 August 2017

Isan Chen

7

1 reference

Europe PubMed Central

20 August 2017

M Dror Michaelson

8

1 reference

Europe PubMed Central

20 August 2017

language of work or name

0 references

publication date

1 March 2009

1 reference

Europe PubMed Central

20 August 2017

Journal of Oncology Practice

1 reference

Europe PubMed Central

20 August 2017

5

1 reference

Europe PubMed Central

20 August 2017

2

1 reference

Europe PubMed Central

20 August 2017

66-70

1 reference

Europe PubMed Central

20 August 2017

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

23 August 2017

Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

23 August 2017

Prognostic value of thrombocytosis in renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

23 August 2017

Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

23 August 2017

Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

23 August 2017

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

23 August 2017

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

23 August 2017

Renal-cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

23 August 2017

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

23 August 2017

Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: results from a phase III randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

2 September 2018

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

2 September 2018

Can patient satisfaction with quality of life predict survival in advanced colorectal cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

2 September 2018

Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

2 September 2018

Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

2 September 2018

Baseline FACT-G score is a predictor of survival for advanced lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

2 September 2018

Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

2 September 2018

Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

2 September 2018

Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

2 September 2018

Baseline quality of life predicts survival in patients with advanced colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

2 September 2018

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790652

2 September 2018

Characteristics of metastasis as a prognostic factor for immunotherapy in metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20856722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of sorafenib on symptoms and quality of life: results from a large randomized placebo-controlled study in renal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20856722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JOP.0922004

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37466388&oldid=1531337901"